Literature DB >> 10752571

Treatment of advanced Parkinson's disease by unilateral posterior GPi pallidotomy: 4-year results of a pilot study.

M S Baron1, J L Vitek, R A Bakay, J Green, W M McDonald, S A Cole, M R DeLong.   

Abstract

To assess the long-term outcome following unilateral pallidotomy for advanced Parkinson's disease, we performed nonblinded Core Assessment Program for Intracerebral Transplantations protocol assessments in 10 of the original 15 patients in our pilot study for 4 years following surgery. Although Unified Parkinson's Disease Rating Scale motor examination scores returned to baseline levels at 3 and 4 years, most patients continued to show sustained improvements in contralateral tremor, akinesia, and drug-induced dyskinesias. Contralateral tremor was absent at 4 years in all seven patients with preoperative tremor. Contralateral "off" arm movement times (averaged for three tasks) decreased by 37% at 1 year and by 30% at 4 years. Contralateral dyskinesia scores improved by 82% at 1 year and by 64% at 4 years. In contrast, after reaching speeds equal to the contralateral side at 1 year, ipsilateral "off" movement times increased by 13% over baseline levels at 4 years. Although most gait and postural stability measures showed modest initial improvement followed by a return to baseline values, "on" stand-walk-sit task performance declined significantly at 4 years. Despite the restriction of our surgeries to one side and the expected natural progression of Parkinson's disease, the results of patient self-assessments suggest that 4 years after unilateral pallidotomy, most patients continue to experience a quality of life above preoperative levels.

Entities:  

Mesh:

Year:  2000        PMID: 10752571     DOI: 10.1002/1531-8257(200003)15:2<230::aid-mds1005>3.0.co;2-u

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Exendin-4 for Parkinson's disease.

Authors:  Felipe de Jesús Esparza-Salazar; Alma Rosa Lezama-Toledo; Germán Rivera-Monroy; Cesario V Borlongan
Journal:  Brain Circ       Date:  2021-03-30

Review 3.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

4.  Parkinson's Disease: Surgical Options.

Authors:  Helen Bronte-Stewart
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 5.  Parkinson's disease: surgical options.

Authors:  J Hammerstad; P Hogarth
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

6.  Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease.

Authors:  Adriana M Strutt; Eugene C Lai; Joseph Jankovic; Farah Atassi; Elizabeth M Soety; Harvey S Levin; Robert G Grossman; Michele K York
Journal:  Surg Neurol       Date:  2008-06-02

Review 7.  Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Jay L Alberts; Christopher J Hass; Jerrold L Vitek; Michael S Okun
Journal:  Exp Neurol       Date:  2008-07-31       Impact factor: 5.330

8.  Effects of transient focal inactivation of the basal ganglia in parkinsonian primates.

Authors:  Mark S Baron; Thomas Wichmann; Demin Ma; Mahlon R DeLong
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

9.  Deep-learning based fully automatic segmentation of the globus pallidus interna and externa using ultra-high 7 Tesla MRI.

Authors:  Oren Solomon; Tara Palnitkar; Re'mi Patriat; Henry Braun; Joshua Aman; Michael C Park; Jerrold Vitek; Guillermo Sapiro; Noam Harel
Journal:  Hum Brain Mapp       Date:  2021-03-18       Impact factor: 5.038

10.  Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.

Authors:  J Guridi; R González-Redondo; J A Obeso
Journal:  Parkinsons Dis       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.